Laryngeal Dystonia Gravidarum: Sudden Onset of Adductor Spasmodic Dysphonia in Pregnancy

被引:3
作者
Ankola, Ashish [2 ]
Sulica, Lucian [1 ]
Murry, Thomas [1 ]
机构
[1] Weill Cornell Med Coll, Dept Otolaryngol Head & Neck Surg, New York, NY 10021 USA
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
关键词
Adductor spasmodic dysphonia; pregnancy; sudden onset; BOTULINUM TOXIN MANAGEMENT; MYASTHENIA-GRAVIS; NERVE-SECTION; RISK-FACTORS; EXPERIENCE; DISORDERS; RECEPTOR;
D O I
10.1002/lary.24225
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/HypothesisThe purpose of this study was to identify the presence or absence of known factors related to onset of adductor spasmodic dysphonia (ADSD) in a population with sudden onset during or after pregnancy. Study DesignRetrospective review. MethodsA review of 350 patient records identified five patients with sudden onset of ADSD related to pregnancy. An age-matched group with sudden onset of ADSD not related to pregnancy served as controls. All subjects completed a 20-question survey of risk factors relevant to ADSD. ResultsThe average age of onset in both groups was 31 years. Three had onset of ADSD in the postpartum period, the other two during pregnancy. Significantly increased avocational voice use was found in the pregnant group compared to the control group. There was a significant difference in the two groups regarding cumulative risk factors traditionally associated with ADSD. ConclusionsSudden onset of ADSD can occur in pregnancy in women with clinical profiles that differ from traditional ADSD patients. Level of Evidence3b Laryngoscope, 123:3127-3130, 2013
引用
收藏
页码:3127 / 3130
页数:4
相关论文
共 23 条
  • [1] Selective laryngeal adductor denervation-reinnervation: A new surgical treatment for adductor spasmodic dysphonia
    Berke, GS
    Blackwell, KE
    Gerratt, BR
    Verneil, A
    Jackson, KS
    Sercarz, JA
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1999, 108 (03) : 227 - 231
  • [2] Botulinum toxin management of spasmodic dysphonia (Laryngeal dystonia): A 12-year experience in more than 900 patients
    Blitzer, A
    Brin, MF
    Stewart, CF
    [J]. LARYNGOSCOPE, 1998, 108 (10) : 1435 - 1441
  • [3] Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series
    Blitzer, A.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 28 - 30
  • [4] INHIBITORY EFFECT OF ALPHA-FETOPROTEIN ON THE BINDING OF MYASTHENIA-GRAVIS ANTIBODY TO ACETYLCHOLINE-RECEPTOR
    BRENNER, T
    BEYTH, Y
    ABRAMSKY, O
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (06): : 3635 - 3639
  • [5] Brin M F, 1998, Adv Neurol, V78, P237
  • [6] Patient Perceptions of Factors Leading to Spasmodic Dysphonia: A Combined Clinical Experience of 350 Patients
    Childs, Lesley
    Rickert, Scott
    Murry, Thomas
    Blitzer, Andrew
    Sulica, Lucian
    [J]. LARYNGOSCOPE, 2011, 121 (10) : 2195 - 2198
  • [7] Cogen P H, 1979, Adv Neurol, V26, P123
  • [8] RECURRENT LARYNGEAL NERVE-SECTION FOR SPASTIC DYSPHONIA
    DEDO, HH
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1976, 85 (04) : 451 - 459
  • [9] Dystonia gravidarum: A new case with a long follow-up
    Fasano, Alfonso
    Elia, Antonio E.
    Guidubaldi, Arianna
    Tonali, Pietro A.
    Bentivoglio, Anna Rita
    [J]. MOVEMENT DISORDERS, 2007, 22 (04) : 564 - 566
  • [10] Ferrero Simone, 2008, Expert Rev Neurother, V8, P979, DOI 10.1586/14737175.8.6.979